Denali Therapeutics Inc (DNLI) Insider Trading
- $4,950,000.00
- $331,255,625.57
- Nov. 7, 2024
- Ryan J Watts
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 1, 2021 | Director | 50,000 | $56.62 | Sell | $2,831,000.00 | |
April 1, 2021 | CEO | 18,334 | $56.60 | Sell | $1,037,704.40 | |
March 29, 2021 | Insider | 2,822 | $54.62 | Sell | $154,137.64 | |
March 15, 2021 | CFO | 50,000 | $61.89 | Sell | $3,094,500.00 | |
March 4, 2021 | COO | 10,000 | $61.02 | Sell | $610,200.00 | |
March 3, 2021 | Director | 1,666 | $61.61 | Sell | $102,642.26 | |
Feb. 16, 2021 | CFO | 50,000 | $65.09 | Sell | $3,254,500.00 | |
Feb. 12, 2021 | Major Shareholder | 2,216,798 | $65.00 | Sell | $144,091,870.00 | |
Feb. 11, 2021 | CEO | 9,473 | $70.30 | Sell | $665,951.90 | |
Feb. 11, 2021 | COO | 3,047 | $70.35 | Sell | $214,356.45 | |
Feb. 11, 2021 | Insider | 3,156 | $70.33 | Sell | $221,961.48 | |
Feb. 11, 2021 | CFO | 3,035 | $70.34 | Sell | $213,481.90 | |
Feb. 9, 2021 | CFO | 1,448 | $74.68 | Sell | $108,136.64 | |
Feb. 9, 2021 | COO | 1,468 | $74.80 | Sell | $109,806.40 | |
Feb. 9, 2021 | Insider | 1,470 | $74.68 | Sell | $109,779.60 | |
Feb. 9, 2021 | CEO | 5,112 | $73.79 | Sell | $377,214.48 | |
Feb. 4, 2021 | COO | 10,000 | $67.84 | Sell | $678,400.00 | |
Feb. 1, 2021 | CEO | 18,334 | $68.44 | Sell | $1,254,778.96 | |
Jan. 15, 2021 | CFO | 50,000 | $71.45 | Sell | $3,572,500.00 | |
Jan. 4, 2021 | CEO | 88,334 | $74.96 | Sell | $6,621,516.64 | |
Jan. 4, 2021 | COO | 70,000 | $74.95 | Sell | $5,246,500.00 | |
Dec. 21, 2020 | Director | 25,000 | $90.06 | Sell | $2,251,500.00 | |
Dec. 14, 2020 | Major Shareholder | 17,825 | $80.38 | Sell | $1,432,773.50 | |
Dec. 11, 2020 | Major Shareholder | 46,799 | $80.05 | Sell | $3,746,259.95 | |
Nov. 12, 2020 | Director | 30,000 | $70.05 | Sell | $2,101,500.00 | |
Nov. 4, 2020 | Director | 10,000 | $50.18 | Sell | $501,800.00 | |
Oct. 9, 2020 | Insider | 30,000 | $41.22 | Sell | $1,236,600.00 | |
Sept. 10, 2020 | Insider | 3,689 | $31.00 | Sell | $114,359.00 | |
June 29, 2020 | Major Shareholder | 82,578 | $24.01 | Sell | $1,982,697.78 | |
June 26, 2020 | Major Shareholder | 122,077 | $23.94 | Sell | $2,922,523.38 | |
June 22, 2020 | Major Shareholder | 90,056 | $24.78 | Sell | $2,231,587.68 | |
June 19, 2020 | Major Shareholder | 144,920 | $24.54 | Sell | $3,556,336.80 | |
June 16, 2020 | Director | 400,000 | $26.10 | Sell | $10,440,000.00 | |
March 30, 2020 | CEO | 4,807 | $19.48 | Sell | $93,640.36 | |
March 30, 2020 | COO | 1,427 | $19.49 | Sell | $27,812.23 | |
March 30, 2020 | CFO | 1,428 | $19.48 | Sell | $27,817.44 | |
Feb. 26, 2020 | Major Shareholder | 3,894,764 | $20.25 | Sell | $78,868,971.00 | |
Dec. 23, 2019 | Insider | 3,464 | $20.01 | Sell | $69,314.64 | |
Dec. 19, 2019 | Insider | 2,566 | $20.00 | Sell | $51,320.00 | |
Dec. 4, 2019 | COO | 7,500 | $18.26 | Sell | $136,950.00 | |
Dec. 4, 2019 | CEO | 21,268 | $18.26 | Sell | $388,353.68 | |
Nov. 25, 2019 | COO | 14,125 | $18.02 | Sell | $254,532.50 | |
Nov. 25, 2019 | CEO | 42,185 | $18.02 | Sell | $760,173.70 | |
Nov. 22, 2019 | CEO | 1,300 | $18.00 | Sell | $23,400.00 | |
Nov. 22, 2019 | COO | 646 | $18.00 | Sell | $11,628.00 | |
Sept. 9, 2019 | COO | 7,500 | $18.16 | Sell | $136,200.00 | |
Sept. 5, 2019 | CEO | 8,581 | $18.05 | Sell | $154,887.05 | |
Aug. 7, 2019 | COO | 7,500 | $18.81 | Sell | $141,075.00 | |
July 8, 2019 | COO | 7,500 | $20.28 | Sell | $152,100.00 | |
July 8, 2019 | Insider | 17,500 | $20.29 | Sell | $355,075.00 |
Insiders are both buying and selling Denali Therapeutics Inc stock.
The insider traders at Denali Therapeutics Inc are: Ryan J Watts, Alexander O Schuth, Carole Ho, Steve E Krognes, Vicki L Sato, Marc Tessier-Lavigne, Douglas K Bratton, Vicki L. Sato, Alexander O. Schuth, Steve E. Krognes, Ryan J. Watts, David P Schenkein, Jennifer E Cook, and David P. Schenkein
The most active insider trader at Denali Therapeutics Inc is Ryan J Watts with 36 trades.
Douglas K Bratton has sold the most Denali Therapeutics Inc stock with a total value of $382,924,890.09.
Douglas K Bratton has bought the most Denali Therapeutics Inc stock with a total value of $9,900,000.00.
The most recent insider trade for Denali Therapeutics Inc was on Nov. 7, 2024.
The single biggest insider buy for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $4,950,000.00 on Dec. 12, 2017.
The single biggest insider sell for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $144,091,870.00 on Feb. 12, 2021.